SMAD2 and atrial fibrillation: These results suggest that AF-MSC-hypoCM, containing growth factors, enhances the proliferation and migration of dermal fibroblasts via PI3K/Akt and TGF-β/SMAD2 pathways, and accelerates wound healing.